News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Joshua Meeks: Multi-omic T1 analysis for BCG response
Joshua Meeks/X
Dec 25, 2024, 22:25

Joshua Meeks: Multi-omic T1 analysis for BCG response

Joshua Meeks, Urologic Oncologist and Scientist at Northwestern University, shared a post on X:

“Very excited for bioRxiv on multi-omic (RNA-seq, targeted mutations, single-cell, spatial) T1 analysis for BCG response.

Genomic and transcriptomic profiling of high-risk bladder cancer reveals diverse molecular and microenvironment ecosystems.”

Genomic and transcriptomic profiling of high-risk bladder cancer reveals diverse molecular and microenvironment ecosystems

Authors: Khyati Meghani, Yanni Yu, Noahh Frydenlund, Erik Z Li, Bonnie Choy, Sarki Abdulkadir, Joshua J Meek

Joshua Meeks

bioRxiv bladder cancer Bonnie Choy cancer Erik Z Li Joshua J Meek Joshua Meeks Khyati Meghani Noahh Frydenlund Northwestern University OncoDaily Oncology Sarki Abdulkadir Yanni Yu
Special Coverage
Blog
May 4, 2025, 07:01
UICC Highlights Study Linking Cancer and Higher Risk of Drug-Resistant Infections
Societies
May 4, 2025, 06:43
STAR-TREC Study Shows successful Organ Preservation with Chemoradiotherapy or Short-Course Radiotherapy, Reducing the Need for Surgery in Early-Intermediate Stage Rectal Cancer Patients
Blog
May 4, 2025, 06:41
Peter Pisters: Pleased to start the day at MD Anderson Cancer Center's Research Town Hall for AACR25
Blog
May 4, 2025, 06:36
Ahmed Magdy Rabea: Pleasure to join my friend Amr Shafik at CAIRO Journal Club – Lung 360 meeting
Blog
May 4, 2025, 06:30
Medicaid Cancer Foundation participated in the official opening of the Nigerian Cancer Society Secretariat
Science
May 4, 2025, 06:29
Preferred Paper at ESTRO 2025: risk factors for acute gastrointestinal (GI) toxicity during EBRT and concurrent chemotherapy in LACC
Blog
May 4, 2025, 06:11
Zhen Su: The era of Immun-oncology 2.0 is here
Societies
May 4, 2025, 05:42
PRIME-RT a randomized phase Il trial: Durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC)
Blog
May 4, 2025, 05:23
Tinatin Alaverdashvili: Proud to be one of the 19 mentees selected for the ESTRO Mentoring Programme
Blog
May 4, 2025, 05:16
Icro Meattini: Landed in Vienna for ESTRO25
Blog
May 4, 2025, 05:10
Amy C. Moore: En route to spend time with friends and colleagues at HOPE Summit25
Blog
May 4, 2025, 05:00
Emil Lou: AACR25 marked the Scientist Survivor Program's 27th year